Database Lock for Non-Hodgkin’s Lymphoma Study

We are delighted to announce the achievement of a huge milestone in the Non-Hodgkin’s Lymphoma Phase II trial. Database for this oncology study was locked last Thursday, 18 April 2019.

This is a randomized, parallel group multicenter international study. Global Clinical Trials has been responsible for the full support of the trial in Ukraine, including regulatory support, site selection, and monitoring at the Ukrainian sites.

Thank you to everyone participating in the study for your hard work and efforts. Now GCT is preparing for study close-out.

Image credit: Kiev, in public domain

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.